Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsURETHRALGeneric

MUSE

ALPROSTADIL

Standard Dose
0.25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MUSE is listed in Drugs@FDA under application 020700 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ALPROSTADIL Form and strength SUPPOSITORY;URETHRAL - 0.25MG Sponsor VIATRIS Submission history Latest submission status date: 2024-05-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview MUSE is listed in Drugs@FDA under application 020700 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ALPROSTADIL Form and strength SUPPOSITORY;URETHRAL - 0.25MG Sponsor VIATRIS Submission history Latest submission status date: 2024-05-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.